Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Respiratory viral threats.

Frederick G Hayden1

  • 1Department of Internal Medicine, University of Virginia School of Medicine, Box 800473, Charlottesville, VA 22908, USA. fgh@virginia.edu

Current Opinion in Infectious Diseases
|March 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiviral Resistance in Influenza: Clinical and Public Health Implications.

Influenza and other respiratory viruses·2026
Same author

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.

The New England journal of medicine·2026
Same author

Influenza A(H3N2) Subclade K Virus: Threat and Response.

JAMA·2025
Same author

Introduction and Update: Advances in Influenza Therapeutics.

The Journal of infectious diseases·2025
Same author

Modeling Influenza Antiviral Strategies: Reducing Burden and Preventing Resistance.

The Journal of infectious diseases·2025
Same author

A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Emerging respiratory viruses like avian influenza (A/H5N1) and SARS-CoV pose significant pandemic threats. While progress is made in interventions, effective vaccines and antivirals for many respiratory viruses remain elusive.

Area of Science:

  • Virology
  • Public Health
  • Epidemiology

Background:

  • Emerging respiratory viral threats pose a significant global health concern.
  • Avian influenza (A/H5N1) and severe acute respiratory syndrome coronavirus (SARS-CoV) are key examples of zoonotic viral threats.
  • Seasonal influenza significantly impacts pediatric populations, necessitating broader immunization strategies.

Purpose of the Study:

  • To review peer-reviewed literature from 2005 on emerging respiratory viral threats.
  • To assess the current state of knowledge regarding pandemic influenza and other novel respiratory viruses.
  • To evaluate the progress in developing interventions for respiratory viral infections.

Main Methods:

  • Literature review of peer-reviewed publications from 2005.

Related Experiment Videos

  • Analysis of data on viral epizootics and human cases.
  • Assessment of molecular diagnostic techniques for virus identification.

    • Main Results:

    • The expanding epizootic of avian A/H5N1 influenza raises pandemic concerns, with studies highlighting potential for interspecies transmission.
    • Antiviral agents are crucial for influenza response, but supply limitations and resistance are concerns.
    • Molecular diagnostics have identified new coronaviruses and a respiratory parvovirus, and clarified the impact of human metapneumovirus and rhinoviruses on respiratory illnesses and asthma.

    Conclusions:

    • Specific interventions for influenza and SARS-CoV show promise.
    • Effective antivirals and vaccines are still lacking for many other emerging respiratory viruses.
    • Continued research and development are essential to address the threat of respiratory viral pathogens.